Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 is now shown in the page footer, replacing Revision: v3.2.0. There are no significant changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedDeleted the government funding status banner from the study page, and core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedThe label 'Last Update Posted' is updated to 'Last Update Posted (Estimated)' in the Study Record Dates. This is a minor metadata change that does not affect the study details or outcomes.SummaryDifference0.1%

- Check27 days agoChange DetectedNo significant changes were detected on the Study Details page. Core sections such as title, conditions, eligibility criteria, design, and outcome measures appear unchanged.SummaryDifference0.5%

- Check56 days agoChange DetectedKey changes indicate a shift to current operating status and updated versioning (e.g., Active status, current date fields, and new revision v3.2.0), while removing older recruitment and contact details and earlier dates.SummaryDifference4%

- Check63 days agoChange DetectedUpdated revision to v3.1.0 and added new contact details (phone extension and email), replacing the previous v3.0.2 revision.SummaryDifference0.1%

Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.